Couldn’t Pfizer buy the B platform without buyin
Post# of 72440
I think people who believe that Big Pharma wouldn’t take advantage of IPIX’s precarious predicament are somewhat incorrect, yes, they would look at the value, current and future. But the only way to avoid being taken advantage of in the business world is to be dealing with saints, of which there ain’t many, or with competition similar to what occurred with that other company story that someone posted.
BWDIK? I hope Leo sells rights to the platform. I don’t know what the price would be but it would be nice to see them get the money to advance Kevetrin.